olezarsen sodium

FDA Drug Profile — TRYNGOLZA

olezarsen sodium is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including TRYNGOLZA. Available dosage form: injection, solution.

Drug Details

Generic Name
olezarsen sodium
Brand Names
TRYNGOLZA
Application Number
NDA218614
Sponsor
Ionis Pharmaceuticals, Inc.
NDC Codes
3
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
OLEZARSEN SODIUM

Indications and Usage

1 INDICATIONS AND USAGE TRYNGOLZA ® is indicated as an adjunct to diet: To reduce triglycerides (TG) in adults with familial chylomicronemia syndrome (FCS). To reduce TG and the risk of acute pancreatitis in adults with severe hypertriglyceridemia (sHTG: TG greater than or equal to 500 mg/dL). TRYNGOLZA is an apolipoprotein C-III (apoC-III)-directed antisense oligonucleotide (ASO) indicated as an adjunct to diet: To reduce triglycerides (TG) in adults with familial chylomicronemia syndrome (FCS). ( 1 ) To reduce TG and the risk of acute pancreatitis in adults with severe hypertriglyceridemia (sHTG: TG greater than or equal to 500 mg/dL). ( 1 )